Related Experiment Video
Updated: May 16, 2026

Cytotoxicity Assays with Zebrafish Cell Lines
Published on: January 6, 2023
Cytotoxic Effects of Cnidarian Venoms: One Cancer, Two Cell Lines
Khouloud Azaiez1, Nurçin Killi2, Kemal Emir Türk3
1Graduate School of Natural and Applied Sciences, Fisheries Engineering Program, Muğla Sıtkı Koçman University, Muğla, Türkiye.
Abstract:
This study aimed to evaluate the cytotoxic effects of jellyfish venoms on two different colon cancer cell lines and to compare their activity with that observed in a healthy colon cell line used as a control. Venoms were isolated from specimens of Aurelia aurita, Rhopilema nomadica, and Anemonia sulcata collected in their natural habitats. These venoms were applied to HT29 and Caco2 colon cancer cell lines, as well as to the CCD18co healthy colon cell line cultured in vitro. The IC₅₀ values of the venoms were determined using the MTT assay. Given the IC₅₀ results, A. aurita displayed the highest cytotoxic potency, R. nomadica showed a moderate and cell line-dependent effect, and A. sulcata exhibited a delayed, high-dose cytotoxicity profile, becoming clearly evident at 72 h. Based on these results, Annexin-V, ROS, and MMP analyses were performed to investigate the mechanisms of cell death. Our findings showed that A. aurita venom was more effective on HT29 cells after 48 h and caused minimal damage to CCD18co healthy cells. A. sulcata venom exhibited cytotoxic effects on HT29 cells at both 48 and 72 h, while exerting limited toxicity on healthy CCD18co cells. R. nomadica venom showed cytotoxicity on Caco2 cells at 48 h. Among the three venoms, R. nomadica exhibited the highest cytotoxic effect on CCD18co healthy colon cells. In conclusion, venoms from all three Cnidarian species demonstrated cytotoxic effects on two different colon cancer cell lines. The cytotoxicity was found to be apoptosis-related. Moreover, the venoms showed selective activity across different cancer cell lines.
Insights
Jellyfish venoms from Aurelia aurita, Rhopilema nomadica, and Anemonia sulcata show cytotoxic effects on colon cancer cells. These natural compounds exhibit selective activity, with potential for apoptosis-related cell death mechanisms.
Area of Science:
- Marine Biology
- Pharmacology
- Cancer Research
Background:
- Jellyfish venoms are complex mixtures of bioactive compounds.
- Natural products are increasingly explored for therapeutic applications, including cancer treatment.
- Colon cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the cytotoxic effects of Aurelia aurita, Rhopilema nomadica, and Anemonia sulcata venoms on colon cancer cell lines (HT29, Caco2).
- To compare the venom cytotoxicity against cancer cells versus a healthy colon cell line (CCD18co).
- To elucidate the mechanisms underlying venom-induced cell death.
Main Methods:
- Venom isolation from collected cnidarian specimens.
- In vitro cell culture of HT29, Caco2, and CCD18co cell lines.
- MTT assay to determine half-maximal inhibitory concentration (IC₅₀) values.
- Annexin-V, reactive oxygen species (ROS), and mitochondrial membrane potential (MMP) assays to analyze cell death pathways.
Main Results:
- Aurelia aurita venom demonstrated the highest cytotoxic potency against HT29 cells with minimal toxicity to CCD18co cells.
- Anemonia sulcata venom showed delayed cytotoxicity on HT29 cells, with limited impact on healthy cells.
- Rhopilema nomadica venom exhibited moderate, cell line-dependent cytotoxicity, with the highest effect on CCD18co cells among the tested venoms.
- Cell death was confirmed to be apoptosis-related.
Conclusions:
- Cnidarian venoms possess significant cytotoxic potential against colon cancer cell lines.
- The venoms display selective toxicity, affecting cancer cells more than healthy cells.
- Apoptosis is a key mechanism in venom-induced cancer cell death, highlighting their potential as a source for novel anti-cancer agents.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Cell Lines
Cancers Originate from Somatic Mutations in a Single Cell
Inhibition of Cdk Activity
Cancer
